Gibson, W. & Wagg, A. Incontinence in the elderly, ‘normal’ ageing, or unaddressed pathology? Nat. Rev. Urol. 14, 440–447 (2017).
Pfisterer, M. H., Griffiths, D. J., Schaefer, W. & Resnick, N. M. The effect of age on lower urinary tract function: a study in women. J. Am. Geriatr. Soc. 54, 405–412 (2006).
Dubeau, C. E. The aging lower urinary tract. J. Urol. 175, S11–S15 (2006).
Chapple, C. R. et al. Lower urinary tract symptoms revisited: a broader clinical perspective. Eur. Urol. 54, 563–569 (2008).
McDonough, R. C. & Ryan, S. T. Diagnosis and management of lower urinary tract dysfunction. Surg. Clin. North Am. 96, 441–452 (2016).
Yoshimura, N. & Chancellor, M. B. Neurophysiology of lower urinary tract function and dysfunction. Rev. Urol. 5, S3–S10 (2003).
PubMed PubMed Central Google Scholar
Jacobsen, S. J., Girman, C. J. & Lieber, M. M. Natural history of benign prostatic hyperplasia. Urology 58, 5–16 (2001).
CAS Article PubMed Google Scholar
Hansen, B. L. Lower urinary tract symptoms (LUTS) and sexual function in both sexes. Eur. Urol. 46, 229–334 (2004).
Azadzoi, K. M. & Siroky, M. B. Mechanisms of lower urinary tract symptoms in pelvic ischemia. J. Biochem. Pharmacol. Res. 1, 64–74 (2013).
PubMed PubMed Central Google Scholar
Speich, J. E. et al. Are oxidative stress and ischemia significant causes of bladder damage leading to lower urinary tract dysfunction? Neurourol. Urodyn. 39, S16–S22 (2020).
Munro, D. & Treberg, J. R. A radical shift in perspective: mitochondria as regulators of reactive oxygen species. J. Exp. Biol. 220, 1170–1180 (2017).
Duchen, M. R. Mitochondria and calcium: from cell signaling to cell death. J. Physiol. 529, 57–68 (2000).
CAS Article PubMed PubMed Central Google Scholar
Bayir, H. & Kagan, V. E. Bench to bedside: mitochondrial injury, oxidative stress and apoptosis. Crit. Care 12, 206 (2008).
Article PubMed PubMed Central Google Scholar
Cadenas, E. & Davies, K. J. Mitochondrial free radical generation, oxidative stress and aging. Free Rad. Biol. Med. 29, 222–230 (2000).
CAS Article PubMed Google Scholar
Effendi, W. I., Nagano, T., Kobayashi, K. & Nishimura, Y. Focusing on adenosine receptors as a potential targeted therapy in human diseases. Cells 9, 24 (2020).
Jackson, E. K., Gillespie, D. G. & Mi, Z. 8-Aminoguanosine and 8-aminoguanine exert diuretic, natriuretic, glucosuric, and antihypertensive activity. J. Pharmacol. Exp. Ther. 359, 420–435 (2016).
CAS Article PubMed PubMed Central Google Scholar
Jackson, E. K. & Tofovic, S. P. Methods for treatment using small molecule potassium-sparing diuretics and natriuretics. US Patent No. 10,729,711 (2020).
Osborne, W. R. & Barton, R. W. A rat model of purine nucleoside phosphorylase deficiency. Immunology 59, 63–67 (1986).
CAS PubMed PubMed Central Google Scholar
Jackson, E. K. & Mi, Z. 8-Aminoguanosine exerts diuretic, natriuretic, and glucosuric activity via conversion to 8-aminoguanine, yet has direct antikaliuretic effects. J. Pharmacol. Exp. Ther. 363, 358–366 (2017).
CAS Article PubMed PubMed Central Google Scholar
Chern, J. W. et al. Nucleosides. 5. Synthesis of guanine and formycin B derivatives as potential inhibitors of purine nucleoside phosphorylase. J. Med. Chem. 36, 1024–1031 (1993).
CAS Article PubMed Google Scholar
Jackson, E. K., Mi, Z., Kleyman, T. R. & Cheng, D. 8-Aminoguanine induces diuresis, natriuresis, and glucosuria by inhibiting purine nucleoside phosphorylase and reduces potassium excretion by inhibiting Rac1. J. Am. Heart Assoc. 7, e010085 (2018).
CAS Article PubMed PubMed Central Google Scholar
Shibata, S. et al. Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat. Med. 14, 1370–1376 (2008).
CAS Article PubMed Google Scholar
Shibata, S. et al. Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway. J. Clin. Invest. 121, 3233–3243 (2011).
CAS Article PubMed PubMed Central Google Scholar
Bzowska, A., Kulikowska, E. & Shugar, D. Purine nucleoside phosphorylases: properties, functions, and clinical aspects. Pharmacol. Ther. 88, 349–425 (2000).
CAS Article PubMed Google Scholar
Roberts, E. L., Newton, R. P. & Axford, A. T. Plasma purine nucleoside phosphorylase in cancer patients. Clin. Chim. Acta 344, 109–114 (2004).
CAS Article PubMed Google Scholar
Silva, R. G. et al. Purine nucleoside phosphorylase activity in rat cerebrospinal fluid. Neurochem. Res. 29, 1831–1835 (2004).
Bortolotti, M., Polito, L., Battelli, M. G. & Bolognesi, A. Xanthine oxidoreductase: one enzyme for multiple physiological tasks. Redox Biol. 41, 101882 (2021).
CAS Article PubMed PubMed Central Google Scholar
Snyder, F. F., Yuan, R. G., Bin, J. C., Carter, K. L. & McKay, D. J. Human guanine deaminase: cloning, expression and characterisation. Adv. Exp. Med. Biol. 486, 111–114 (2000).
CAS Article PubMed Google Scholar
Birder, L. A. et al. Purine nucleoside phosphorylase inhibition ameliorates age-associated lower urinary tract dysfunctions. JCI Insight 5, 15 (2020).
Haskó, G., Sitkovsky, M. V. & Szabó, C. Immunomodulatory and neuroprotective effects of inosine. Trends Pharmacol. Sci. 25, 152–157 (2004).
Article CAS PubMed Google Scholar
Bhattacharyya, S. et al. Oral inosine persistently elevates plasma antioxidant capacity in Parkinson’s disease. Mov. Disord. 31, 417–421 (2016).
CAS Article PubMed Google Scholar
Cipriani, S., Bakshi, R. & Schwarzschild, M. A. Protection by inosine in a cellular model of Parkinson’s disease. Neuroscience 274, 242–249 (2014).
CAS Article PubMed Google Scholar
Gelain, D. P. et al. Extracellular inosine is modulated by H2O2 and protects Sertoli cells against lipoperoxidation and cellular injury. Free Radic. Res. 38, 37–47 (2004).
CAS Article PubMed Google Scholar
Gudkov, S. V., Shtarkman, I. N., Smirnova, V. S., Chernikov, A. V. & Bruskov, V. I. Guanosine and inosine display antioxidant activity, protect DNA in vitro from oxidative damage induced by reactive oxygen species, and serve as radioprotectors in mice. Radiat. Res. 165, 538–545 (2006).
CAS Article PubMed Google Scholar
Ruhal, P. & Dhingra, D. Inosine improves cognitive function and decreases aging-induced oxidative stress and neuroinflammation in aged female rats. Inflammopharmacology 26, 1317–1329 (2018).
CAS Article PubMed Google Scholar
Teixeira, F. C. et al. Inosine protects against impairment of memory induced by experimental model of Alzheimer disease: a nucleoside with multitarget brain actions. Psychopharmacology 237, 811–823 (2020).
CAS Article PubMed Google Scholar
Bellaver, B. et al. Guanosine inhibits LPS-induced pro-inflammatory response and oxidative stress in hippocampal astrocytes through the heme oxygenase-1 pathway. Purinergic Signal. 11, 571–580 (2015).
CAS Article PubMed PubMed Central Google Scholar
Gerbatin, R. D. R. et al. Guanosine protects against traumatic brain injury-induced functional impairments and neuronal loss by modulating excitotoxicity, mitochondrial dysfunction, and inflammation. Mol. Neurobiol. 54, 7585–7596 (2017).
Article CAS PubMed Google Scholar
Hansel, G. et al. Guanosine protects against cortical focal ischemia. involvement of inflammatory response. Mol. Neurobiol. 52, 1791–1803 (2015).
CAS Article PubMed Google Scholar
Luo, Y. et al. Guanosine and uridine alleviate airway inflammation via inhibition of the MAPK and NF-kappaB signals in OVA-induced asthmatic mice. Pulm. Pharmacol. Ther. 69, 102049 (2021).
CAS Article PubMed Google Scholar
Zizzo, M. G. et al. Preventive effects of guanosine on intestinal inflammation in 2, 4-dinitrobenzene sulfonic acid (DNBS)-induced colitis in rats. Inflammopharmacology 27, 349–359 (2019).
留言 (0)